A CASE REPORT OF A NURSE WHO RECEIVED THE COVID-19 VACCINE

Year 2022, Volume: 2 Issue: 2, 44 - 49, 06.04.2022

Leyla Kaya Zahide Kaya

Abstract

Throughout history, societies have struggled with infectious diseases. It is important to prevent the spread of infectious diseases. Vaccination is the major tool of defense that prevents the rapid spread of infectious diseases in society. Therefore, the successful implementation of the vaccination program during the pandemic is very important. A variety of vaccines has been available for Covid-19, one of the biggest pandemics of the last century. This study was conducted to determine the side effects of Sinovac, one of the COVID -19 vaccines, in humans. The case presented is a 40-year-old male patient who had a blood pressure of 190/110 and a heart rate of 140 measured 10 minutes after vaccination on January 15, 2021. Describing dizziness, palpitations, and darkening of the eyes, the patient stated that he had never had a cardiac problem before. He applied to the emergency department of Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Education Research Hospital. Sinus tachycardia was diagnosed as a result of electrocardiography (ECG). For 20 days, blood pressure ranged between 150/90 and 140/90 while the average heart rate was generally measured to be 140. He used Beloc 25 mg Tablet for 20 days. According to the findings of this study, Sinovac has an effect on blood pressure. However, it is recommended that larger-scale studies be conducted.

Keywords

adverse effects, COVID-19, health personnel, vaccine, vaccine hesitancy.

References

• 1. World Health Organization. Coronavirus Disease (COVID-19) [Internet]. 2020. Available from: https://www.who.int/health-topics/coronavirus. Available date: Marc 1, 2022
• 2. Worldometer. COVID-19 Coronavirüs Pandemic [Internet]. 2022. Available from: https://www.worldometers.info/coronavirus/. Available date: Marc 1, 2022
• 3. World Health Organization. Coronavirus disease (COVID-19): Herd immunity, lockdowns and COVID-19 [Internet]. 2021. Available from: https://www.who.int/news-room/questions-and-answers/item/herd-immunity-lockdowns-and-covid-19. Available date: Marc 1, 2022
• 4. Ndwandwe D, Wiysonge CS. COVID-19 vaccines. Curr Opin Immunol [Internet]. 2021;71:111–6. Available from: https://doi.org/10.1016/j.coi.2021.07.003
• 5. Türki̇ye i̇laç ve Tibbi̇ Ci̇haz Kurumu. Kamooyunun Dikkatine [Internet]. 2020. Available from: https://www.titck.gov.tr/haber/kamuoyunun-dikkatine-13012021185623. Available date: Marc 1, 2022
• 6. Türk Tabipler Birliği. Yeni Koronavirüs Pandemisi Sürecinde Türkiye’de Covıd-19 Aşılaması Ve Bağışıklama Hizmetlerinin Durumu [Internet]. 2021. Available from: https://www.ttb.org.tr/userfiles/files/yeni_koronavirus_pandemisi_surecinde_turkiyede_covid19_asilamasi_ve_bagisiklama_hizmetlerinin_durumu.pdf. Available date: Marc 1, 2022
• 7. Center for Health Protection. Vaccination Fact Sheet for CoronaVac [Internet]. 2022. Available from: https://www.covidvaccine.gov.hk/pdf/COVID19VaccinationFactSheet_CoronaVac_ENG.pdf. Available date: Marc 1, 2022
• 8. Cerci P, Ucan A. Immediate Type Systemic Hypersensitivity Reactions After the Inactivated SARS-CoV-2 Vaccine in Healthcare Workers. Osmangazi J Med. 2022;44(1):53–60.
• 9. Yavuz E. COVID-19 Aşıları. 2020;24(4):227–34.
• 10. Ertalay A, Öner F. Aşılar ve Aşı Adjuvanları. 2001;21–33.
• 11. Velipaşaoğlu S. Aşı İmmünitesi ve Yanıtını Ttkileyen Faktörler. Osmangazi J Med. 2020;1–5.
• 12. Gopinathannair R, Olshansky B. Management of tachycardia. F1000Prime Rep. 2015;7(May):3–7.
• 13. Yusuf S. Deciphering the Sinus Tachycardias. Clin Cardiol. 2005;28:267–76.
• 14. Olshansky B, Sullivan RM. Inappropriate sinus tachycardia. Europace. 2019;21(2):194–207.
• 15. Nwokocha CR, Bafor EE, Ajayi OI, Ebeigbe AB. The malaria-high blood pressure hypothesis: Revisited. Am J Hypertens. 2020;33(8):695–702.
• 16. Julius S. Tachycardia in Hypertension: A Saga of Progress Despite Prejudice, Confusion, and Inertia. Prog Cardiovasc Dis [Internet]. 2009;52(1):26–30. Available from: http://dx.doi.org/10.1016/j.pcad.2009.06.002
• 17. Reule S, Drawz PE. Heart rate and blood pressure: Any possible implications for management of hypertension. Curr Hypertens Rep. 2012;14(6):478–84.
• 18. Ilerigelen B. Beta-blockers in cardiovascular prevention. Updat Cardiol. 2019;2(1):1–6.
• 19. The Standart. Another Man Died After Receiving Sinovac Vaccine [Internet]. 2021. Available from: https://www.thestandard.com.hk/breaking-news/section/4/168519/Another-man-died-after-receiving-Sinovac-vaccine. Available date: Marc 1, 2022
• 20. İslam MM, Ademoğlu E, Bayram S, Osaydan Satıcı M, Eroğlu SE. A mortal Covid-19 case with SARS-CoV-2 variant VOC-202012 / 01 after two doses of CoronaVac ® vaccination , case report. 2022;11–3.
• 21. Food and Drug Administration. Reports of Suspected Adverse Reaction to COVID-19 Vaccines [Internet]. Republic of the Philippines Department of Health. 2021 [cited 2022 Mar 13]. Available from: https://www.fda.gov.ph. Available date: Marc 1, 2022
• 22. Canpolat U, Atalar E. Kalp Hızı Ve Kan Basıncı: Hipertansiyon Tedavisine Farklı Pencereden Bakış. TGKD. 2014;18(3).
• 23. Bloomberg. More Than 10.9 Billion Shots Given: Covid-19 Tracker [Internet]. 2022. Available from: https://www.bloomberg.com/graphics/covid-vaccine-tracker-global-distribution/. Available date: Marc 1, 2022
• 24. Harrison EA, Wu JW. Vaccine confidence in the time of COVID-19. Eur J Epidemiol [Internet]. 2020;35(4):325–30. Available from: https://doi.org/10.1007/s10654-020-00634-3.
• 25. Rodrigues CMC, Plotkin SA. Impact of Vaccines; Health, Economic and Social Perspectives. Front Microbiol. 2020;11(July).
• 26. Ozisik L, Tanriover MD, Altınel S, Unal S. Vaccinating healthcare workers: Level of implementation, barriers and proposal for evidence-based policies in Turkey. Hum Vaccines Immunother. 2017;13(5):1198–206.
• 27. Kaya L, Aydın-Kartal Y. Hesitancy towards a COVID-19 vaccine among midwives in Turkey during the COVID-19 pandemic: A cross-sectional web-based survey. Eur J Midwifery. 2022;6(January):1–8.